Shimadzu (7701) AI Stock Analysis

• Market Cap: $1.15T
• Dividend Yield: 1.5%
• Average Volume (3M): 736.29K
• Price to Earnings (P/E): 22.1
• Beta (1Y): 0.67
• Revenue Growth: 4.01%
• EPS Growth: -6.45%
• Country: JP
• Employees: 14,519
• Sector: Technology
• Sector Strength: 88
• Industry: Hardware, Equipment & Parts
• EPS (TTM): 27.42
• Shares Outstanding: 296,070,250
• 10 Day Avg. Volume: 746,230
• 30 Day Avg. Volume: 736,290
• PEG Ratio: -3.94
• Price to Book (P/B): 2.19
• Price to Sales (P/S): 2.03
• P/FCF Ratio: 29.62
• Enterprise Value/Market Cap: 0.78
• Enterprise Value/Revenue: 1.67
• Enterprise Value/Gross Profit: 3.81
• Enterprise Value/Ebitda: 10.05
• 1Y Price Target: $4,886.07
• Price Target Upside: 17.74% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 3

• Rating: 75 Outperform
• Price Target: ¥4,573.00 ▲(10.19% Upside)

Shimadzu's strong financial performance is the most significant factor, supported by healthy revenue and profit growth, and a solid balance sheet. Technical analysis indicates positive momentum, though caution is advised due to overbought signals. Valuation metrics suggest the stock may be slightly overvalued, which tempers the overall score.

Shimadzu Business Overview & Revenue Model

Company Description

Shimadzu Corporation (7701) is a global leader in the fields of analytical and measuring instruments, medical systems, and industrial equipment. Founded in 1875 and headquartered in Kyoto, Japan, the company operates across various sectors including healthcare, environmental, and materials testing. Core products and services include chromatographs, mass spectrometers, X-ray imaging systems, and clinical diagnostics, catering to a diverse clientele that ranges from laboratories and hospitals to manufacturing and research institutions.

How the Company Makes Money

Shimadzu generates revenue through multiple streams, primarily from the sale of high-precision instruments and equipment used in laboratories and medical settings. Its key revenue streams include the sale of analytical instruments, medical imaging solutions, and environmental and industrial testing systems. The company also earns income from maintenance services, consumables, and software solutions associated with its equipment. Significant partnerships with educational institutions, research organizations, and healthcare providers enhance its market reach and support its sales efforts. Additionally, Shimadzu invests in R&D to innovate and develop new technologies, which helps maintain its competitive edge and drive future growth.

Shimadzu Financial Statement Overview

Summary

Shimadzu demonstrates strong financial health with consistent revenue growth, robust profit margins, and effective cost management. The balance sheet is solid with low financial leverage, and cash flow generation is healthy, supporting sustainable growth.

Income Statement

Shimadzu has shown consistent revenue growth with a notable increase in total revenue over recent years. The gross profit margin is strong, indicating efficient production and cost management. The net profit margin is healthy, reflecting solid profitability. EBIT and EBITDA margins are robust, suggesting effective operational management.

Balance Sheet

The company maintains a strong equity position relative to its total assets, leading to a favorable equity ratio. The debt-to-equity ratio is low, indicating prudent financial leverage. Return on equity is solid, demonstrating effective use of shareholder funds to generate profits.

Cash Flow

Shimadzu's cash flow from operations is strong and covers its capital expenditures, leading to positive free cash flow. The free cash flow growth rate is favorable, showing increasing cash generation. The operating cash flow to net income ratio is solid, indicating good cash conversion efficiency.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	540.48B	539.05B	511.89B	482.24B	428.18B	393.50B
Gross Profit	237.62B	234.44B	220.84B	200.96B	178.62B	156.19B
EBITDA	90.08B	91.90B	95.81B	89.02B	82.55B	65.74B
Net Income	51.71B	53.77B	57.04B	52.05B	47.29B	36.10B
Balance Sheet
Total Assets	647.30B	672.18B	673.96B	618.87B	560.53B	497.46B
Cash, Cash Equivalents and Short-Term Investments	137.95B	143.41B	165.28B	159.27B	157.97B	112.76B
Total Debt	11.07B	11.75B	11.91B	11.27B	11.59B	10.26B
Total Liabilities	153.75B	174.10B	181.63B	195.37B	179.37B	161.96B
Stockholders Equity	493.54B	498.06B	492.33B	423.50B	381.16B	335.50B
Cash Flow
Free Cash Flow	0.00	36.90B	14.63B	31.46B	53.24B	50.49B
Operating Cash Flow	0.00	52.00B	30.13B	48.30B	63.37B	63.80B
Investing Cash Flow	0.00	-23.17B	-16.00B	-34.51B	-6.04B	-13.86B
Financing Cash Flow	0.00	-48.41B	-21.10B	-19.42B	-15.66B	-13.03B

Shimadzu Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 4150.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7701, the sentiment is Positive. The current price of 4150 is above the 20-day moving average (MA) of 4002.35, above the 50-day MA of 3788.89, and above the 200-day MA of 3712.04, indicating a bullish trend. The MACD of 125.53 indicates Negative momentum. The RSI at 65.61 is Neutral, neither overbought nor oversold. The STOCH value of 64.74 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7701.

Shimadzu Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6951	―	¥271.22B	13.56	―	1.94%	10.15%	-18.57%
6856	―	$528.75B	14.59	11.91%	0.73%	7.09%	6.00%
7701	―	$1.15T	22.07	10.54%	1.50%	4.01%	-6.45%
6965	―	$493.13B	33.82	4.46%	2.19%	0.66%	-52.50%
6645	―	$832.00B	25.44	4.20%	2.41%	1.05%	―
Sector *	―	$37.18B	12.37	-10.20%	1.83%	8.50%	-7.62%
7732	―	$346.26B	―	-0.73%	1.28%	-2.92%	-319.34%

Shimadzu Corporate Events

Shimadzu Corporation Reports Mixed Q1 2025 Results

Shimadzu Corporation, a prominent player in the analytical and measuring instruments industry, is renowned for its innovative solutions in sectors such as healthcare, medical systems, and industrial machinery. The company is listed on the Tokyo Stock Exchange and continues to advance its technological capabilities.

Shimadzu Corporation Reports Q1 2025 Financial Results with Mixed Performance

Shimadzu Corporation reported its consolidated financial results for the three months ending June 30, 2025, showing a slight increase in net sales by 1.2% year-on-year. However, the company experienced a decline in ordinary profit and profit attributable to owners of the parent by 17.3% and 20.7%, respectively. The financial results indicate challenges in maintaining profit margins despite increased sales, impacting the company’s short-term financial performance and potentially influencing its strategic decisions moving forward.

The most recent analyst rating on (JP:7701) stock is a Buy with a Yen5800.00 price target. To see the full list of analyst forecasts on Shimadzu stock, see the JP:7701 Stock Forecast page.